The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Really can't understand where all this enthusiam is coming from. Just because they are launching a new product everything is going to be rosy in the garden. They are losing money, fund raise probably due within a year or so, 30m outstanding share options so the Directors are looking after themselves. This in my opinion is a traders share.... nothing more. !
Https://editshare.com/editshare-and-blackbird-partnership-expands-cloud-video-editing-workflows/
Does anyone on here have any experience of EditShare? I used an AI chat bot earlier and found out about EditShare but would be great to know what it's like to use from anyone here who might have used it
Imagicomm Stations Expand Cloud Editing with Blackbird
https://www.tvtechnology.com/equipment/imagicomm-stations-expand-cloud-editing-with-blackbird
https://www.blackbird.video/soundbites/
Hey Pokerchips,
Long time no speak here as the BIRD was grounded......hopefully it seems like good, very good 👌 news just awaiting onnfirmation via official RNS.,meanwhile the BIRD is flaxing its wings 🪽....
ATB.
The BIRD is back airborne ....
so much is being done in terms of the new product launch marketing preparations etc , it is already creating some anticipated excitement
https://elevate.io/
https://www.blackbird.video/soundbites/
Flying at long last ....
End of long grounding period.
There ya go
We can only hope
Looks like overhang may have cleared yesterday. Enormous volume has changed hands over past few weeks.
Coming soon....very soon....
With all hopes pinned on the new offering it is good to know that it remains on track for delivery by the end of Q1.
MikeyB55,
BIRD is lost on the US market...just one tiddler amongst thousands
You can have Dollars,Euro and Sterling on many retail broker accounts so..you can buy direct from the UK market in your own currency.... no need for ADR really
Only a few US broker held the shares anyway
BT cancelled their US listing back in 2019
Anyone with an ADR can just swap them for shares ..no big deal
Being on the exchange in the US is only worthwhile if you are also going to commit to invest in North American investor relations - which will cost $100-$200k each year to do it properly. Better to save the money for marketing of new product. Share price will look after itself once user numbers click upwards.
Giving up on the US listing as they are launching their new b2c product is a bit confusing. I would have thought they would have left this to well after the launch as it would ha e driven US visibility in investment markets. It makes no sense to cancel this now. They are also trying to keep it under the radar with the timing of the RNS. Maybe even the execs don't believe in this company anymore. New untested product, shift from b2b to b2c - this is a complete new offer to a new market. Reflects that they have given up on the old product. Goingbto need a lot more that fluffy announcements from Ian to get this back on track.
Nothing to see here. There has been less than a handful of trades on the OTCQX market in the last quarter so cancellation before the 2024 fees are due on 1 Jan is no big deal.
I was trying to find earlier what markets you can trade blackbird shares through but didn't have much luck. My thoughts are they're either saving a bit of money, about £30,000 a year, and/or they're making it simpler for a potential acquisition in the new year. Not sure to be honest, times like this I wish I'd paid better attention at school.
Does this RNS signal the end for Blackbird? I thought they were flying, no pun intended :(
...or P & D....... :-(
6.00p....could be the end,of this long downtrend..imo
Professionals read sector blogs,forums, social media like LinkedIn etc via Followers etc etc .... easiest to reach...professionals will be the first to know the product is coming and may well be amongst those Testing it ...
Sumit and Mo came over from Sony Vegas Pro which has over a million paying subscribers, so they will know the people to target.
They believe Blackbird’s technology is another level, and their initial target is over a million subscribers.
There will be a basic Freemium package which is important to get elevate.io viral.
Then it’s $12.99 per month for the basic package, then between $30 and $60 for professionals.
The problem here is that they are entering a completely new market. How are they going to sell the product to customers who they have had minimal or no previous involvement. Assuming the product will be sold as SaaS with initial charge followed by annual fee based on usage, sales to enterprises will take time to negotiate. This means I can see cash flow becoming a serious problem to Blackbird.
Adios. At this point, I am thankful they are not taking on any large new customers with new demands on the b2b side. Focus....
Race to the bottom here I think. They have given up on the b2b product completely. Have built a new b2c product and are hoping to launch. This is in effect a startup then, with no proven product market fit. This will take a while to validate. Enjoy reading the bs comparing the company to Figma. Insider pumpers . Good luck all. I'm out now and just taking the loss